The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer

Biomarkers

Volumn 19, Issue 6, 2014, Pages 444-451

  Jiang, Nan ^a,b   Deng, Jing Yu ^a,b   Liu, Yong ^a,b   Ke, Bin ^a,b   Liu, Hong Gen ^a,b   Liang, Han ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Gastric carcinoma; Neutrophil lymphocyte ratio; Platelet lymphocyte ratio; Prognosis

Indexed keywords

FLUOROURACIL; FOLINATE CALCIUM;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; POSTOPERATIVE COMPLICATION; PREDICTION; RADICAL RESECTION; RECEIVER OPERATING CHARACTERISTIC; STOMACH CANCER; SURGICAL INFECTION; SURVIVAL; TREATMENT OUTCOME; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; IMMUNOLOGY; KAPLAN MEIER METHOD; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; MORTALITY; NEUTROPHIL; PREOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STOMACH NEOPLASMS; THROMBOCYTE COUNT; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PLATELET COUNT; PREOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; STOMACH NEOPLASMS;

EID: 84906347746     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.926567     Document Type: Article

References (24)

1. Aliustaoglu M, Bilici A, Ustaalioglu BB, et al. (2010). The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol 27:1060-5.
2. An X, Ding PR, Li YH, et al.(2010). Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers 15:516-22.
3. Bhatti I, Peacock O, Lloyd G, et al. (2010). Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet- lymphocyte ratio. Am J Surg 200:197-203.
4. Cho H, Kim JH. (2009). Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer. Biomarkers 14:161-70.
5. Cihan YB, Ozturk A, Mutlu H. (2014). Relationship between prognosis and neutrophil:lymphocyte and platelet:lymphocyte ratios in patients with malignant pleural mesotheliomas. Asian Pac J Cancer Prev 15: 2061-7.
6. Domínguez I, Fernández-del Castillo C. (2012). Preoperative platelet- lymphocyte ratio in resected pancreatic ductal carcinoma: is it meaningful? Am J Surg 203:412. doi: 10.1016/j.amjsurg.2009.05.022.
7. Donskov F, von der Maase H. (2006). Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol 24: 1997-2005.
8. Hussein MR, Ahmed RA. (2005). Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin. Cancer Biol Ther 4:819-21.
9. Kacan T, Babacan NA, Seker M, et al. (2014). Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers? Asian Pac J Cancer Prev 15:2089-94
10. Kaynar M, Yildirim ME, Badem H, et al. (2014). Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio. Tumour Biol. [Epub ahead of print]. DOI: 10.1007/s13277-014- 1889-x.
11. Kwon KA, Kim SH, Oh SY, et al. (2010). Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 10:203.
12. Kwon H-C, Kim SH, Oh SY, et al. (2012). Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 17:216-22.
13. Li QG, Li P, Tang D, et al. (2013). Impact of postoperative complications on long-term survival after radical resection for gastric cancer. WJG 19:4060-5.
14. Martin HL, Ohara K, Kiberu A, et al. (2014). Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Intern Med J. [Epub ahead of print]. doi: 10.1111/imj.12453.
15. McMillan DC, Wotherspoon HA, Fearon KC, et al. (1995). A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170: 319-22.
16. Nakajima K, Ochiai T, Suzuki T, et al. (1998). Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients. Tumour Biol 19:464-9.
17. Petrie HT, Klassen LW, Kay HD. (1985). Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 134:230-4.
18. Schmidt H, Suciu S, Punt CJ, et al. (2007). Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol 25:1562-9.
19. Shau HY, Kim A. (1988). Suppression of lymphokine-activated killer induction by neutrophils. J Immunol 141:4395-402.
20. Shimada H, Nabeya Y, Okazumi S, et al. (2003). Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 83: 248-52.
21. Shimada H, Oohira G, Okazumi S, et al. (2004). Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 198:737-41.
22. Shimada H, Takiguchi N, Kainuma O, et al. (2010). High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13:170-6.
23. Teramukai S, Kitano T, Kishida Y, et al. (2009). Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 45: 1950-8.
24. Walsh SR, Cook EJ, Goulder F, et al. (2005). Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91: 181-4.